Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report
Journal of Cellular and Molecular Anesthesia · 22.06.2026 · 11 (2)
DOI: 10.5812/jcma-171715 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cellular and Molecular Anesthesia, online erschienen am 22.06.2026. Verfasst von Seyed Alireza Seyed Siamdoust und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
The co-occurrence of neurofibromatosis type 1 (NF1) and type 1 diabetes mellitus (T1DM) in a surgical patient presents a rare, high-stakes anesthetic challenge. NF1 is associated with potentially difficult airways, vasculopathies, and catecholamine-secreting tumors, whereas T1DM requires meticulous perioperative glycemic control. Following a systematic literature search in PubMed and Scopus, we found no specific combined guideline for this dual diagnosis. This report aims to clarify the critical interactions between these disorders and propose an evidence-informed framework. Case Presentation: A 42-year-old woman (ASA III) with confirmed NF1 and T1DM presented for recurrent surgical debridement. Her NF1 phenotype included substantial posterior neck muscle hypertrophy; a thick neck with a neck circumference of 58 cm; pronounced neck stiffness with a sternomental distance of 6 cm; Mallampati class III airway anatomy suggestive of macroglossia; inability of the lower incisors to bite the upper lip; and adequate mouth opening, with an inter-incisor distance of 4.5 cm measured between the upper and lower incisors during maximal mouth opening. A significant history of intraoperative hypoglycemia during previous procedures was noted.
Conclusions
This single-case observation suggests that successful perioperative management may depend on a proactive, protocol-driven strategy. Key elements include a primary airway plan that avoids paralysis, strict adherence to T1DM glucose protocols, and an anesthetic technique that prioritizes cardiovascular stability. This hypothesis-generating report provides a preliminary framework for clinical contexts in which standardized guidelines are lacking.
Zitieren
APA
Siamdoust, S. A. S., Zaman, B., Amiraslani, T., Noorizad, S., Zahedi, S., & Akhoondinasab, M. R. (2026). Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report. Journal of Cellular and Molecular Anesthesia, 11(2). https://doi.org/10.5812/jcma-171715
Vancouver
Siamdoust SAS, Zaman B, Amiraslani T, Noorizad S, Zahedi S, Akhoondinasab MR. Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report. Journal of Cellular and Molecular Anesthesia. 2026;11(2). doi:10.5812/jcma-171715
BibTeX
@article{Siamdoust2026,
author = {Siamdoust, Seyed Alireza Seyed and Zaman, Behrooz and Amiraslani, Taymaz and Noorizad, Samad and Zahedi, Selda and Akhoondinasab, Mohammad Reza},
title = {Anesthesia Management in an NF1 Patient with Type 1 Diabetes: A Case Report},
journal = {Journal of Cellular and Molecular Anesthesia},
year = {2026},
volume = {11},
number = {2},
doi = {10.5812/jcma-171715}
}
EUVIMED